Current Epidemiology of Pneumocystis Pneumonia
Pneumocystis pneumonia (PCP) has historically been one of the leading causes of disease among persons with AIDS. The introduction of highly active antiretroviral therapy in industrialized nations has brought about dramatic declines in the incidence of AIDS-associated complications, including PCP. In...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Centers for Disease Control and Prevention
2004-10-01
|
| Series: | Emerging Infectious Diseases |
| Subjects: | |
| Online Access: | https://wwwnc.cdc.gov/eid/article/10/10/03-0985_article |
| _version_ | 1811270671160836096 |
|---|---|
| author | Alison Morris Jens D. Lundgren Henry Masur Peter D. Walzer Debra L. Hanson Toni Frederick Laurence Huang Charles B. Beard Jonathan E. Kaplan |
| author_facet | Alison Morris Jens D. Lundgren Henry Masur Peter D. Walzer Debra L. Hanson Toni Frederick Laurence Huang Charles B. Beard Jonathan E. Kaplan |
| author_sort | Alison Morris |
| collection | DOAJ |
| description | Pneumocystis pneumonia (PCP) has historically been one of the leading causes of disease among persons with AIDS. The introduction of highly active antiretroviral therapy in industrialized nations has brought about dramatic declines in the incidence of AIDS-associated complications, including PCP. In the adult population, the incidence of PCP has significantly decreased, but it remains among the most common AIDS-defining infections. Similar declines have been documented in the pediatric population. In much of the developing world, PCP remains a significant health problem, although its incidence among adults in sub-Saharan Africa has been debated. This review discusses the epidemiology of PCP during the current era of the AIDS epidemic. Although fewer cases of PCP occur in the industrialized countries, increasing drug-resistant HIV infections, possible drug-resistant PCP, and to the tremendous number of AIDS cases in developing countries make this disease of continued public health importance. |
| first_indexed | 2024-04-12T22:06:15Z |
| format | Article |
| id | doaj.art-6006c85f910e481881d62897f2a00036 |
| institution | Directory Open Access Journal |
| issn | 1080-6040 1080-6059 |
| language | English |
| last_indexed | 2024-04-12T22:06:15Z |
| publishDate | 2004-10-01 |
| publisher | Centers for Disease Control and Prevention |
| record_format | Article |
| series | Emerging Infectious Diseases |
| spelling | doaj.art-6006c85f910e481881d62897f2a000362022-12-22T03:14:55ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592004-10-0110101713172010.3201/eid1010.030985Current Epidemiology of Pneumocystis PneumoniaAlison MorrisJens D. LundgrenHenry MasurPeter D. WalzerDebra L. HansonToni FrederickLaurence HuangCharles B. BeardJonathan E. KaplanPneumocystis pneumonia (PCP) has historically been one of the leading causes of disease among persons with AIDS. The introduction of highly active antiretroviral therapy in industrialized nations has brought about dramatic declines in the incidence of AIDS-associated complications, including PCP. In the adult population, the incidence of PCP has significantly decreased, but it remains among the most common AIDS-defining infections. Similar declines have been documented in the pediatric population. In much of the developing world, PCP remains a significant health problem, although its incidence among adults in sub-Saharan Africa has been debated. This review discusses the epidemiology of PCP during the current era of the AIDS epidemic. Although fewer cases of PCP occur in the industrialized countries, increasing drug-resistant HIV infections, possible drug-resistant PCP, and to the tremendous number of AIDS cases in developing countries make this disease of continued public health importance.https://wwwnc.cdc.gov/eid/article/10/10/03-0985_articlePneumocystis jiroveciiPneumocystis pneumoniaPCPepidemiologyHIVhighly active antiretroviral therapy |
| spellingShingle | Alison Morris Jens D. Lundgren Henry Masur Peter D. Walzer Debra L. Hanson Toni Frederick Laurence Huang Charles B. Beard Jonathan E. Kaplan Current Epidemiology of Pneumocystis Pneumonia Emerging Infectious Diseases Pneumocystis jirovecii Pneumocystis pneumonia PCP epidemiology HIV highly active antiretroviral therapy |
| title | Current Epidemiology of Pneumocystis Pneumonia |
| title_full | Current Epidemiology of Pneumocystis Pneumonia |
| title_fullStr | Current Epidemiology of Pneumocystis Pneumonia |
| title_full_unstemmed | Current Epidemiology of Pneumocystis Pneumonia |
| title_short | Current Epidemiology of Pneumocystis Pneumonia |
| title_sort | current epidemiology of pneumocystis pneumonia |
| topic | Pneumocystis jirovecii Pneumocystis pneumonia PCP epidemiology HIV highly active antiretroviral therapy |
| url | https://wwwnc.cdc.gov/eid/article/10/10/03-0985_article |
| work_keys_str_mv | AT alisonmorris currentepidemiologyofpneumocystispneumonia AT jensdlundgren currentepidemiologyofpneumocystispneumonia AT henrymasur currentepidemiologyofpneumocystispneumonia AT peterdwalzer currentepidemiologyofpneumocystispneumonia AT debralhanson currentepidemiologyofpneumocystispneumonia AT tonifrederick currentepidemiologyofpneumocystispneumonia AT laurencehuang currentepidemiologyofpneumocystispneumonia AT charlesbbeard currentepidemiologyofpneumocystispneumonia AT jonathanekaplan currentepidemiologyofpneumocystispneumonia |